STAT+: WHO warns the world is still failing to develop desperately needed antibiotics
Despite mounting concern over antibiotic resistance, a new report finds that none of 43 antibiotics…
Category: STAT+
Opinion: STAT+: Rethinking triage in an era of vaccine nationalism
Just about every schoolchild learns that Napoleon Bonaparte was a small man. But few know…
STAT+: FDA is urged to move faster to list medicines withdrawn over safety concerns
Arguing patient safety is at risk, an advocacy group is urging the Food and Drug…
STAT+: Tango Therapeutics to go public in $353 million SPAC deal
Cambridge biotech Tango Therapeutics is going public through a $353 million deal with a special…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Heralding a ‘societal transformation’ in health care, Mayo Clinic launches two companies to harness patient data
Mayo Clinic is forming a pair of companies to collect and analyze data from remote…
.jpg)
STAT+: A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements
In what is being called a win for consumers, a U.S. appeals court upheld a…
STAT+: PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold…
STAT+: Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Europe tries to lower drug prices with small doses of transparency
For countries in Europe, negotiating a deal with a pharma company over drug prices is…
STAT+: Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies…
STAT+: Microsoft to buy Nuance Communications for $19.7 billion
Microsoft announced on Monday that it has agreed to acquire Burlington-based artificial intelligence and technology…
STAT+: Cavazzoni to take over influential spot atop FDA drug center
WASHINGTON — Patrizia Cavazzoni has been named the permanent leader of the FDA’s Center for…
STAT+: Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Amazon established a foothold in diagnostics during Covid-19. Now it’s doubling down
Vin Gupta’s hiring in January 2020 could not have come at a better time for…
STAT+: Sage drug reduces muscle tremor but with significant side effects, study results show
Sage Therapeutics said Monday that its experimental pill was more effective than a placebo in…
Opinion: STAT+: Three steps toward creating a functioning U.S. biosimilars market
The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching…
STAT+: iTeos Therapeutics debuts first data on TIGIT-targeting cancer immunotherapy
ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that…
STAT+: Revolution Medicines seeks to bolster case for its lead cancer drug
Revolution Medicines on Saturday presented updated data to bolster the case for its lead cancer…
STAT+: Researchers see a ‘tractable approach’ to taming chromosomal metastasis
The latest hope for stopping untreatable cancers traces its roots to a turn-of-the-century German zoologist,…
STAT+: Early trial shows promise aiming a modified cold-sore virus against brain tumors in children
A therapy that sends a modified cold-sore virus to selectively kill tumor cells and spark…
STAT+: Clinical study reports hold more details about the side effects of cancer drugs
For years, researchers have urged regulators to release clinical study reports that are generated during…
STAT+: Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Natural killer cells, primed with an antibody, induce remissions in patients with advanced blood cancer
Two patients with advanced Hodgkin lymphoma were told their tumors were so resistant to treatment…
STAT+: Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs
A Brazilian Supreme Court judge suspended extensions for pharmaceutical patents in the country, and although…
STAT+: Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Digital pharmacy startup Thirty Madison taps former Lilly exec as president
After nearly three decades working at two of the world’s pharmaceutical giants, Michelle Carnahan is…
Opinion: STAT+: Unprecedented development of Covid-19 vaccines, treatments points to biopharma’s future
Business as usual has not been the mantra for companies developing Covid-19 vaccines and drugs….
STAT+: ‘Here to stay’: How the pandemic helped build a burgeoning home testing industry
Just a few years ago, the idea of at-home testing was practically antithetical to Caesar…
STAT+: Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug
Following a three-year probe, Merck (MRK) reached a deal with Austrian regulators to end a…
STAT+: How artificial intelligence could make clinical trials smarter
Clinical trials have a dirty little secret. For all the careful work that goes into…
STAT+: Massachusetts General Hospital president Peter Slavin to depart after 18 years
The president of Massachusetts General Hospital, Dr. Peter L. Slavin, plans to step down after…
STAT+: Pharmalittle: U.S. is prohibited from sharing Covid-19 shots with other countries; U.S. officials knew of problems at Emergent plant
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?
There’s more money sloshing around in biotech than ever before. Over the past year, several…
STAT+: Fibrogen admits false heart-safety data for experimental anemia pill shared with FDA, investors
Fibrogen acknowledged Tuesday that the company has been touting false heart-safety data for its experimental…
STAT+: A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs
After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on…
STAT+: California once again delays launch of a closely watched prescription drug purchasing program
For the second time this year, California officials have delayed a much-ballyhooed effort to start…
STAT+: MIT scientists launch Future Founders Initiative to solve biotech’s ‘missing women’ problem
A group of prominent MIT scientists that formed to address gender inequities in the biotech…
STAT+: Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
As chief of Boston Children’s Hospital, one of the most esteemed pediatric hospitals in the…
STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production
Top of the morning, and a fine one it is. Clear blue skies and a…
STAT+: There’s no point person in Biden’s HHS for its $186 billion Covid-19 fund for health care providers
WASHINGTON — Health care providers are eagerly awaiting billions of dollars from a Covid-19 relief…
STAT+: Lilly is a holdout among companies that agree to disclose when executive pay is clawed back
A coalition of institutional investors is pushing Eli Lilly to adopt a policy to disclose…
STAT+: Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: FDA cites lack of evidence in rejecting Acadia Pharma’s bid to expand use of anti-psychosis drug
Acadia Pharmaceuticals said Monday that U.S. regulators had rejected its application seeking to expand the…
STAT+: Bristol Myers agrees to pay $75 million to settle allegations of underpaying Medicaid rebates
After years of litigation, Bristol-Myers Squibb (BMY) agreed to pay $75 million, plus interest, to…
STAT+: Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot
And so, another working week will soon draw to a close. Not a moment too…
An antitrust expert weighs in on the FTC’s complaint against Illumina
Spare a thought for Illumina. The $56 billion dollar titan of genomics has become the…
STAT+: FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections
In a stern letter, the U.S. Office of Special Counsel rebuked the Food and Drug…
STAT+: Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill
Top of the morning to you. A spot of rain is descending on the Pharmalot…
STAT+: Former Medicare leader Seema Verma joins board of health tech firm Lumeris
She was President Trump’s top Medicare official. Now, Seema Verma, the former Centers for Medicare…